Abstract
Our gastrointestinal tract is host to a wide variety of bacteria, together referred to as the microbiota. These bacteria influence our health and well-being through many different mechanisms. Most of these effects are the result of metabolites that are being produced by these bacteria or through triggering the expression of metabolites by the host. In this chapter we will highlight two bacterial species that have remarkable metabolic features that make them prime candidates for the development as next-generation probiotics. The first is Eubacterium hallii, a bacterium that is capable of producing two important short-chain fatty acids (SCFAs), propionate and butyrate. The other bacterium is Intestinimonas butyriciproducens, a bacterium that is capable of producing butyrate from not only sugars but also lysine and even glycated lysine. Both species also can produce pseudovitamin B12. We will discuss conditions that can result in the production of specific metabolites and the implications this can have on human health.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belenguer A et al (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72(5):3593–3599. https://doi.org/10.1128/AEM.72.5.3593
Belzer C et al (2017) Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B 12 production by intestinal symbionts. MBio 8(5):e00770–e00717. https://doi.org/10.1128/mBio.00770-17
Boets E et al (2017) Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. J Physiol 595(2):541–555. https://doi.org/10.1113/JP272613
Bolognini D et al (2016) The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol 89(3):388–398. https://doi.org/10.1124/mol.115.102301
Bourriaud C et al (2005) Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J Appl Microbiol 99(1):201–212. https://doi.org/10.1111/j.1365-2672.2005.02605.x
Brownlee M (1994) Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 43(6):836–841. https://doi.org/10.2337/diab.43.6.836
Bui TPN, de Vos WM, Plugge CM (2014) Anaerostipes rhamnosivorans sp. nov., a human intestinal, butyrate-forming bacterium. Int J Syst Evol Microbiol 64(PART 3):787–793. https://doi.org/10.1099/ijs.0.055061-0
Bui TPN et al (2015) Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat Commun 6:1–10. https://doi.org/10.1038/ncomms10062
Bui TPN et al (2016) Comparative genomics and physiology of the butyrate-producing bacterium Intestinimonas butyriciproducens. Environ Microbiol Rep 8(6):1024–1037. https://doi.org/10.1111/1758-2229.12483
Chambers ES et al (2015) Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64(11):1744–1754. https://doi.org/10.1136/gutjnl-2014-307913
Collins MD et al (1994) The phylogeny of the genus clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 44(4):812–826. https://doi.org/10.1099/00207713-44-4-812
Crobach MJT et al (2020) The bacterial gut microbiota of adult patients infected, colonized or noncolonized by clostridioides difficile. Microorganisms 8(5):1–13. https://doi.org/10.3390/microorganisms8050677
De Vos P et al (eds) (2009) Bergey’s manual of Systematic Bacteriology; volume three, the firmicutes. second. Springer International Publishing, Dordrecht Heidelberg London New York. https://doi.org/10.1007/b92997
Degnan PH, Taga ME, Goodman AL (2014) Vitamin B12as a modulator of gut microbial ecology. Cell Metab 20(5):769–778. https://doi.org/10.1016/j.cmet.2014.10.002
Den Besten G et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325–2340. https://doi.org/10.1194/jlr.R036012
Deppe VM et al (2011) Enzymatic deglycation of Amadori products in bacteria: mechanisms, occurrence and physiological functions. Appl Microbiol Biotechnol 90(2):399–406. https://doi.org/10.1007/s00253-010-3083-4
Duncan SH, Louis P, Flint HJ (2004) Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70(10):5810–5817. https://doi.org/10.1128/AEM.70.10.5810
Engels C et al (2016) The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation. Front Microbiol 7:1–12. https://doi.org/10.3389/fmicb.2016.00713
Fekry MI et al (2016) The strict anaerobic gut microbe Eubacterium hallii transforms the carcinogenic dietary heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Environ Microbiol Rep 8(2):201–209. https://doi.org/10.1111/1758-2229.12369
Gänzle MG (2015) Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage. Curr Opin Food Sci 2:106–117. https://doi.org/10.1016/j.cofs.2015.03.001
Harmsen HJMM et al (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68(6):2982–2990. https://doi.org/10.1128/AEM.68.6.2982-2990.2002
Holmes E et al (2012) Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med 4(137). https://doi.org/10.1126/scitranslmed.3004244
Hove H, Nordgaard-Andersen I, Mortensen PB (1994) Faecal DL-lactate concentration in 100 gastrointestinal patients. Scand J Gastroenterol 29(3):255–259. https://doi.org/10.3109/00365529409090473
Hu Y et al (2013) Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 4:2151. https://doi.org/10.1038/ncomms3151
Kläring K et al (2013) Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int J Syst Evol Microbiol 63(PART 12):4606–4612. https://doi.org/10.1099/ijs.0.051441-0
Li F et al (2008) Coupled ferredoxin and crotonyl coenzyme A (CoA) reduction with NADH catalyzed by the butyryl-CoA dehydrogenase/Etf complex from Clostridium kluyveri. J Bacteriol 190(3):843–850. https://doi.org/10.1128/JB.01417-07
Li J et al (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32(8):834–841. https://doi.org/10.1038/nbt.2942
Lin Y et al (1995) Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture. Br J Nutr 74(2):197–207. https://doi.org/10.1079/BJN19950123
Louis P et al (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12(2):304–314. https://doi.org/10.1111/j.1462-2920.2009.02066.x
Marquet P et al (2009) Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 299(2):128–134. https://doi.org/10.1111/j.1574-6968.2009.01750.x
McNabney SM, Henagan TM (2017) Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients 9(12):1–28. https://doi.org/10.3390/nu9121348
Metchnikoff É (1907) The prolongation of life, optimistic studies. In: Mitchell PC (ed) The prolongation of life: optimistic studies. G.P. Putnam’s Sons, New York & London. https://archive.org/details/prolongationofli00metciala
Moens F, Verce M, De Vuyst L (2017) Lactate- and acetate-based cross-feeding interactions between selected strains of lactobacilli, bifidobacteria and colon bacteria in the presence of inulin-type fructans. Int J Food Microbiol 241:225–236. https://doi.org/10.1016/j.ijfoodmicro.2016.10.019
Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3):189–200. https://doi.org/10.1080/19490976.2015.1134082
Oleskin AV, Shenderov BA (2019) Probiotics and psychobiotics: the role of microbial neurochemicals. Probiotics Antimicrobial Proteins 11(4):1071–1085. https://doi.org/10.1007/s12602-019-09583-0
Patterson E et al (2014) Gut microbiota, the pharmabiotics they produce and host health. Proc Nutr Soc 73(4):477–489. https://doi.org/10.1017/S0029665114001426
Pingitore A et al (2017) The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab 19(2):257–265. https://doi.org/10.1111/dom.12811
Qin J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65. https://doi.org/10.1038/nature08821
Rajilić-Stojanović M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38(5):996–1047. https://doi.org/10.1111/1574-6976.12075
Schwab C et al (2017) Trophic interactions of infant bifidobacteria and eubacterium hallii during L-fucose and fucosyllactose degradation. Front Microbiol 8:1–14. https://doi.org/10.3389/fmicb.2017.00095
Seetharam B, Alpers DH (1982) Absorption and transport of cobalamin (Vitamin B12). Annu Rev Nutr 2(1):343–369. https://doi.org/10.1146/annurev.nu.02.070182.002015
Shetty SA et al (2017) Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol Rev 41(2):182–199. https://doi.org/10.1093/femsre/fuw045
Shetty SA et al (2018) Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces. Int J Syst Evol Microbiol 68(12):3741–3746. https://doi.org/10.1099/ijsem.0.003041
Thiemann S, Smit N, Strowig T (2016) Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem, and the susceptibility to infections. Curr Top Microbiol Immunol 398:123–146. https://doi.org/10.1007/82_2016_504
Udayappan S et al (2016) Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes 2:16009. https://doi.org/10.1038/npjbiofilms.2016.9
Vital M, Howe A, Tiedje J (2014) Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data. MBio 5(2):1–11. https://doi.org/10.1128/mBio.00889-14.Editor
Vrieze A et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(4):913–916.e7. https://doi.org/10.1053/j.gastro.2012.06.031
Willcox MDP (2013) Characterization of the normal microbiota of the ocular surface. Exp Eye Res 117:99–105. https://doi.org/10.1016/j.exer.2013.06.003
Woese CR, Fox GE (1977) Phylogenetic structure of the prokaryotic domain: the primary kingdoms (archaebacteria/eubacteria/urkaryote/16S ribosomal RNA/molecular phylogeny). Proc Natl Acad Sci U S A 74(11):5088–5090
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Seegers, J.F.M.L., Bui, T.P.N., de Vos, W.M. (2021). Remarkable Metabolic Versatility of the Commensal Bacteria Eubacterium hallii and Intestinimonas butyriciproducens: Potential Next-Generation Therapeutic Microbes. In: Mojgani, N., Dadar, M. (eds) Probiotic Bacteria and Postbiotic Metabolites: Role in Animal and Human Health. Microorganisms for Sustainability, vol 2. Springer, Singapore. https://doi.org/10.1007/978-981-16-0223-8_5
Download citation
DOI: https://doi.org/10.1007/978-981-16-0223-8_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-0222-1
Online ISBN: 978-981-16-0223-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)